MIGS
Lebanon · Founded 2013
About MIGS
MIGS specializes in humanization and the production of antibody and antibody-like molecules that support preclinical studies.
Company Facts
- Founded: 2013
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $100.0K
- Funding stage: M&A
- Last round: Seed (Mar 2014)
- Website: migsantibodies.com
- Phone: (603)643-7178
Social Profiles
Canonical: https://fsome.com/organization/migs-8267014 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.